Nektar Therapeutics
NKTR
NKTR
265 hedge funds and large institutions have $9.21B invested in Nektar Therapeutics in 2017 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 69 increasing their positions, 96 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
265
Holders Change
+62
Holders Change %
+30.54%
% of All Funds
6.02%
Holding in Top 10
14
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+75%
% of All Funds
0.32%
New
84
Increased
69
Reduced
96
Closed
20
Calls
$183M
Puts
$31.8M
Net Calls
+$151M
Net Calls Change
+$126M
Top Buyers
Top Sellers
| 1 |
O
OppenheimerFunds
New York
|
-$607M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$110M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$98.8M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$80M |
| 5 |
BM
Bridger Management
New York
|
-$54.2M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PCM
276
Piermont Capital Management
St. Louis,
Missouri
| – | -$554K | -1,539 | Closed |
|
|
NSEDCP
277
NJ State Employees Deferred Compensation Plan
Trenton,
New Jersey
| – | -$480K | -1,333 | Closed |
|
|
HAG
278
HighPoint Advisor Group
Downers Grove,
Illinois
| – | -$431K | -1,220 | Closed |
|
|
TRCT
279
Tower Research Capital (TRC)
New York
| – | -$406K | -1,128 | Closed |
|
|
SIP
280
Stoneridge Investment Partners
Radnor,
Pennsylvania
| – | -$259K | -720 | Closed |
|
|
AP
281
AHL Partners
London,
United Kingdom
| – | -$254K | -705 | Closed |
|
|
OAM
282
Oppenheimer Asset Management
New York
| – | -$129K | -359 | Closed |
|
|
PWM
283
Perigon Wealth Management
San Francisco,
California
| – | -$121K | -337 | Closed |
|
|
SIAP
284
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
| – | -$72K | -200 | Closed |
|
|
RE
285
RBC Europe
London,
United Kingdom
| – | -$6K | -17 | Closed |
|
286
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$5K | -13 | Closed |
|